Skip to main content
. 2014 Mar 26;10:145–156. doi: 10.2147/VHRM.S54586

Figure 6.

Figure 6

Treatment effect on efficacy measures from baseline to week 52 for PA and non-PA patients with (A) no diabetes, and (B) diabetes.

Note: aMean change from baseline to week 52 following treatment with PMI versus UC, adjusted for baseline values.

Abbreviations: CHD, coronary heart disease; CI, confidence interval; LS, least square; PA, Pacific Asian; SPAA, single-pill amlodipine/atorvastatin; UC, usual care.